2008PubMedRequires access

Gingival crevicular fluid levels of aspartate aminotransferase and alpha2-macroglobulin before and after topical application of metronidazole or scaling and root planing.

Gerhild Knöfler, Regina Purschwitz, Holger Jentsch, Gerd Birkenmeier, Hannelore Schmidt

Open publisher page 8 citations

Abstract

OBJECTIVE: The aim of this study was to compare the influence of topical metronidazole gel application and scaling and root planing on gingival crevicular fluid variables. METHOD AND MATERIALS: In a split-mouth study, 39 volunteers with chronic periodontitis were treated by metronidazole gel or scaling and root planing. Clinical attachment level and probing depth were recorded, and aspartate aminotransferase (AST) and total/transformed Alpha2-macroglobulin were determined in the gingival crevicular fluid at baseline, as well as after 3 and 6 months. RESULTS: Both treatment procedures resulted in a gain of clinical attachment-0.67 mm for metronidazole and 0.50 mm for scaling and root planing (P< .001)-at the end of the study. The median probing depth was significantly reduced by 0.66 mm for metronidazole and 1.00 mm for scaling and root planing (P< .001) after 6 months. No change of AST was found. Alpha2-macroglobulin was significantly reduced for scaling and root planing and metronidazole after 3 and 6 months (P< .001). No significant difference was found between the 2 procedures at any variable. CONCLUSIONS: These data suggest that Alpha2-macroglobulin reflects clinical changes better than AST and that metronidazole and scaling and root planing have the same influence on clinical outcome and biochemical variables in the gingival crevicular fluid.

About this research paper

What this paper is about

OBJECTIVE: The aim of this study was to compare the influence of topical metronidazole gel application and scaling and root planing on gingival crevicular fluid variables. METHOD AND MATERIALS: In a split-mouth study, 39 volunteers with chronic periodontitis were treated by metronidazole gel or scaling and root planing. Clinical attachment level and probing depth were recorded, and aspartate aminotransferase (AST) and total/transformed Alpha2-macroglobulin were determined in the gingival crevicular fluid at baseline, as well as after 3 and 6 months. RESULTS: Both treatment procedures resulted in a gain of clinical attachment-0.67 mm for metronidazole and 0.50 mm for scaling and root planing (P< .001)-at the end of the study. The median probing depth was significantly reduced by 0.66 mm for metronidazole and 1.00 mm for scaling and root planing (P< .001) after 6 months. No change of AST was found. Alpha2-macroglobulin was significantly reduced for scaling and root planing and metronidazole after 3 and 6 months (P< .001). No significant difference was found between the 2 procedures at any variable. CONCLUSIONS: These data suggest that Alpha2-macroglobulin reflects clinical changes better than AST and that metronidazole and scaling and root planing have the same influence on clinical outcome and biochemical variables in the gingival crevicular fluid.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: The aim of this study was to compare the influence of topical metronidazole gel application and scaling and root planing on gingival crevicular fluid variables. METHOD AND MATERIALS: In a split-mouth study, 39 volunteers with chronic periodontitis were treated by metronidazole gel or scaling and root planing. Clinical attachment level and probing depth were recorded, and aspartate aminotransferase (AST) and total/transformed Alpha2-macroglobulin were determined in the gingival crevicular fluid at baseline, as well as after 3 and 6 months. RESULTS: Both treatment procedures resulted in a gain of clinical attachment-0.67 mm for metronidazole and 0.50 mm for scaling and root planing (P< .001)-at the end of the study. The median probing depth was significantly reduced by 0.66 mm for metronidazole and 1.00 mm for scaling and root planing (P< .001) after 6 months. No change of AST was found. Alpha2-macroglobulin was significantly reduced for scaling and root planing and metronidazole after 3 and 6 months (P< .001). No significant difference was found between the 2 procedures at any variable. CONCLUSIONS: These data suggest that Alpha2-macroglobulin reflects clinical changes better than AST and that metronidazole and scaling and root planing have the same influence on clinical outcome and biochemical variables in the gingival crevicular fluid.

Key concepts: Scaling and root planing, Metronidazole, Medicine, Dentistry, Periodontitis, Gingival and periodontal pocket, Clinical attachment loss, Chronic periodontitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Gingival crevicular fluid levels of aspartate aminotransferase and alpha2-macroglobulin before and after topical application of metronidazole or scaling and root planing. — Research Paper | ScholarLens